ANCO upcoming events

ANCO's Giants Night (08/14/2026)

Sat, 15 Aug 2026 00:45:00 GMT

ANCO wants to take you out to the ballgame! Join us at Oracle Park on Friday, August 14th, for an evening of camaraderie, connection, and San Francisco Giants! This exclusive, practitioner-only event is curated specifically for our member community to network, relax, and enjoy the game in style. Spend Friday night unwinding with colleagues, then join us Saturday for ANCO’s ASCO26 Highlights (complimentary to members) for a high-impact review distilling the latest practice-changing data into actionable clinical insights.

The Game Plan:

5:45 PM: Kick things off in our exclusive ANCO Lounge. Enjoy hosted appetizers and beverages while catching up with colleagues before the crowds arrive.
7:15 PM: Game Time - We’ll head to our group seats to watch the Giants take on the Rockies.

Registration:
ANCO MD Members: $30. Each ANCO member can register up to two guests at $60 each. Every ticket comes with a $10 Splash Pass to use for ballpark snacks or that Giants cap you’ve been eyeing! Note: This is a practitioner-only event.

Ticket Info:
Your digital tickets will be emailed directly to you on August 7th (one week before the game). Please ensure your email address we have in our database is current.

ANCO’s ASCO26 Highlights (08/15/2026)

Sat, 15 Aug 2026 17:00:00 GMT

Join us for ANCO’s ASCO26 Highlights taking place at the InterContinental San Francisco on August 15, 2026.

This meeting is complimentary for all ANCO health care provider members!

Meeting Overview

Join us for ANCO’s ASCO26 Highlights, a high-impact review designed to present the most practice-changing data from the world’s premier oncology stage into actionable clinical insights.

This isn't just a summary—it’s a roadmap for the future of oncology. Our expert faculty will bridge the gap between late-breaking research and your practice, placing every advancement into the context of immediate clinical utility.

Industry Registration

Please read below to understand ANCO's industry registration waitlist process.

At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited. Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.

Northern California Genitourinary Cancer Research Forum (09/19/2026)

Sat, 19 Sep 2026 14:30:00 GMT

Join us for the Northern California Genitourinary Cancer Research Forum taking place at the Claremont Resort & Club, September 19, 2026!

Meeting Overview:

Clinical trials are vital to progress in oncology, offering the most promising potential therapies and, often, serving as the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.

We invite you to join us for an innovative one-day multi-disciplinary educational meeting to bridge this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer.

Learning Objectives:

To engage in scientific exchange of in-progress and recently completed clinical trials in genitourinary malignancies.
To discuss best practices in clinical trial enrollment for genitourinary malignancies, including identifying barriers to participation, working creatively on recruitment strategies, and collaborating across institutions.
To raise awareness of available clinical trials in prostate, bladder and kidney cancer in Northern California.
To discuss multidisciplinary collaboration on clinical trials for genitourinary malignancies that involve medical oncology, urology, and/or radiation oncology partnership.

Precision Oncology Symposium 2026 (11/07/2026)

Sat, 07 Nov 2026 08:00:00 GMT

Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!

Meeting Overview

Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the relevance of this approach.

However, the landscape of available diagnostic technologies and targeted drugs is rapidly changing, making it extremely difficult for practicing oncologists and related professionals to stay up to date and to offer their patients the best molecular diagnostic approach possible. By attending this meeting, clinicians will be informed on cutting edge technologies and their optimal clinical application.

Registration

Registration will open in spring 2026.

Industry Registration

What is ANCO’s Industry Registration policy?

At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited.Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

ANCO meetings have spots for up to 45 industry registrations, outside of exhibitors (only exception is MMC, as we go up to 120 Industry).
Once all exhibitors have confirmed their registrants, ANCO will determine how many industry registration spots are available, and will review the waitlist.
Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.